![Yu Sheng Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 144 M $ in data 31/05/2026
Yu Sheng Wu is the founder of TYK Medicines, Inc. He currently holds the title of Chairman & Chief Executive Officer at the company, which was founded in 2017.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/03/2026 | 123.466.000 ( 32,49% ) | 144 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TYK MEDICINES, INC | Amministratore Delegato | 02/11/2017 |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 1 |
|---|---|
TYK Medicines, Inc.
 TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of therapies for cancer treatment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
